Loss of Epithelial Markers and Acquisition of Vimentin Expression in Adriamycin- and Vinblastine-resistant Human Breast Cancer Cell Lines

Cancer Research

Volumn 52, Issue 19, 1992, Pages 5190-5197

  Heckford, Susan E ^a,d   Skerker, Jeffrey M ^a,c   Gelmann, Edward P ^a,b,c   Torn, Jeffrey A ^a   Thompson, Erik W ^a,b   Byers, Stephen W ^a,b  

^a Lombardi Cancer Research Center ^*  (United States)

^b Departments of Anatomy and Cell Biology   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; DESMOPLAKIN; DOXORUBICIN; KERATIN; UVOMORULIN; VIMENTIN; VINBLASTINE;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL TRANSFORMATION; DESMOSOME; DRUG RESISTANCE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; PHENOTYPE; PRIORITY JOURNAL; TIGHT JUNCTION;

ANTIBODIES; BREAST NEOPLASMS; CELL ADHESION MOLECULES; CYTOSKELETAL PROTEINS; DOXORUBICIN; DRUG RESISTANCE; EPITHELIUM; FIBROBLASTS; HUMAN; INTERCELLULAR JUNCTIONS; INTERMEDIATE FILAMENTS; KERATIN; NEOPLASM INVASIVENESS; PHENOTYPE; STAINING AND LABELING; SUPPORT, NON-U.S. GOV'T; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; VERAPAMIL; VIMENTIN; VINBLASTINE;

EID: 0026781976     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Steinert, P. M., and Roop, D. R. Molecular and cellular biology of intermediate filaments. Annu. Rev. Biochem., 57: 593-625, 1988.
2. Bernal, S. D., and Stahel, R. A. Cytoskeleton-associated proteins: their role as cellular integrators in the neoplastic process. CRC Crit. Rev. Oncol. He-matol., 3: 191-204, 1985.
3. Sommers, C. L., Walker-Jones, D., Heckford, S. E., Worland, P., Valverius, E., Clark, R., Stampfer, M., and Gelmann, E. P. Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res., 49:4258-4263, 1989.
4. Sommers, C. L., Thompson, E. W., Torn, J. A., Kemler, R., Gelmann, E. P., and Byers, S. W. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Cell Growth & Differ., 2: 365-372, 1991.
5. Thompson, E. W., Paik, S., Brunner, N., Sommers, C. L., Zugmaier, G., Clarke, R., Shima, T. B., Torn, J., Donahue, S., Lippman, M. E., Martin, G. R., and Dickson, R. B. Association of increased basement membrane-inva-siveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell. Physiol., 150:534-544, 1992.
6. Cattoretti, G., Andreola, S., Clemente, C., D'Amato, L., and Rilke, F. Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas. Br. J. Cancer, 57: 353-357, 1988.
7. Raymond, W. A., and Leong, A.S-Y. Vimentin-a new prognostic parameter in breast carcinoma? J. Pathol., 158: 107-114, 1989.
8. Domagala, W., Lasota, J., Bartowiak, J., Weber, K., and Osborn, M. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am. J. Pathol., 136:219-227,1990.
9. Domagala, W., Leszek, W., Lasota, J., Weber, K., and Osborn, M. Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas. Am. J. Pathol., 137: 1059-1064, 1990.
10. Zarbo, R. J., Gown, A. M., Nagle, R. B., Visscher, D. W., and Crissman, J. D. Anomalous cytokeratin expression in malignant melanoma: one- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas. Mod. Pathol., 3:494-501, 1990.
11. Hendrix, M. J. C., Seftor, E. A., Chu, Y. W., Seftor, R. E. B., Nagle, R. B., McDaniel, K. M., Leong, S. P. L., Yohem, K. H., Leibovitz, A. M., Mey-skens, F. L., Conaway, D. H., Welch, D. R., Liotta, L. A., and Stetler-Stevenson, W. Coexpression of vimentin and keratins by human melanoma tumor cells-correlation with invasive and metastatic potential. J. NaU. Cancer Inst., 84: 165-174, 1992.
12. Batist, G., Tulpule, A., Sinha, B. K., Katki, A. G., Myers, C. E., and Cowan, K. H. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem., 261:15544-15549,1986.
13. Brooks, S. C., Locke, E. R., and Soule, H. D. Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J. Biol. Chem., 248: 6251-6253, 1973.
14. Lippman, M. E., Bolan, G., and Huff, K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res., 36:4595-4601, 1976.
15. Soule, H. D., and McGrath, C. M. Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Lett., 10: 177-189, 1980.
16. Vickers, P. J., Dickson, R. B., Shoemaker, R., and Cowan, K. H. A multidrug- resistant MCF-7 human breast cancer cell line which exhibits crossresistance to antiestrogens and hormone-independent tumor growth in vivo. Mol. Endocrinol., 2:886-892, 1988.
17. Chen, Y. N., Mickley, L. A., Schwartz, A. M., Acton, E. M., Hwang, J. L., and Fojo, A. T. Characterization of Adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein. J. Biol. Chem., 265: 10073-10080, 1990.
18. Chen, C., and Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7: 2745-2752, 1987.
19. Boshart, M., Weber, F., Jahn, G., Dorsch-Hasler, K., Fleckenstein, B., and Schaffner, W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell, 41: 521-530, 1985.
20. Haslinger, A., and Karin, M. Upstream promoter element of the human metallothionein-UA gene can act like an enhancer element. Proc. Natl. Acad. Sci. USA, 82:8572-8576, 1985.
21. Gritz, L., and Davies, J. Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene (Amst.), 25: 179-188, 1983.
22. Bano, M., Lupu, R., Kidwell, W. R., Lippman, M. E., and Dickson, R. B. Production and characterization of mammary-derived growth factor 1 in mammary epithelial cell lines. Biochemistry, 31:610-616, 1992.
23. Hay, E. D. Extracellular matrix, cell skeletons, and embryonic development. Am. J. Med. Genet., 34: 14-29, 1989.
24. Boyer, B., Tucker, G. C., Valles, A. M., Franke, W. W., and Thiery, J. P. Rearrangements of desmosomal and cytoskeletal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells. J. Cell Biol., 109: 1495-1509, 1989.
25. Boyer, B., Tucker, G. C., Valles, A. M., Gavrilovic, J., and Thiery, J. P. Reversible transition towards a fibroblastic phenotype in a rat carcinoma cell line. Int. J. Cancer, 4 (Suppl.); 69-75, 1989.
26. Valles, A. M., Boyer, B., Badet, J., Tucker, G., Barritault, D., and Thiery, J. P. Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proc. Natl. Acad. Sci. USA, 87:1124-1128, 1990.
27. Zuk, A., Matlin, K. S., and Hay, E. D. Type I collagen gel induces Madin-Darby canine kidney cells to become fusiform in shape and Ipse apical-basal polarity. J. Cell Biol., 108: 903-919, 1989.
28. Tamm, I., Cardinale, I., Krueger, J., Murphy, J. S., May, L. T., and Sehgal, P. B. Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J. Exp. Med., 170: 1649-1669, 1989.
29. Weidner, K. M., Behrens, J., Vandekerckhove, J., and Birchmeier, W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol., III: 2097-2108, 1990.
30. Zuk, A., Kleinman, H. K., and Hay, E. D. Culture on basement membrane does not reverse the phenotype of lens derived mesenchyme-like cells. Int. J. Dev. Biol., 33:487-490, 1989.
31. Greenburg, G., and Hay, E. D. Cytoskeleton and thyroglobulin expression change during transformation of thyroid epithelium to mesenchyme-like cells. Development (Camb.), 102: 605-622, 1988.
32. Greenburg, G., and Hay, E. D. Cytodifferentiation and tissue phenotype change during transformation of embryonic lens epithelium to mesenchymelike cells in vitro. Dev. Biol., 115: 363-379, 1986.
33. Greenburg, G., and Hay, E. D. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J. Cell Biol., 95: 333-339, 1982.
34. Potts, J. D., and Runyan, R. B. Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor 0. Dev. Biol., 134: 392-401, 1989.
35. Collins, J. E., Taylor, I., and Garrod, D. R. A study of desmosomes in colorectal carcinoma. Br. J. Cancer, 62: 796-805, 1990.
36. Schipper, J. H., Frixen, U. H., Behrens, J., Unger, A., Jahnke, K., and Birchmeier, W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res., 51:6328-6337, 1991.
37. Shiozaki, H., Tahara, H., Oka, H., Miyata, M., Kobayashi, K., Tamura, S., lihara, K., Doki, Y., Hirano, S., Takeichi, M., and Mori, T. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am. J. Pathol., 139: 17-23, 1991.
38. Shimoyama, Y., and Hirohashi, S. Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett., 57: 131-135, 1991.
39. Shimoyama, Y., and Hirohashi, S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res., 51: 2185-2192, 1991.
40. Shimoyama, Y., Hirohashi, S., Hirano, S., Noguchi, M., Shimosato, Y., Takeichi, M., and Abe, O. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res., 49: 2128-2133, 1989.
41. Eidelman, S., Damsky, C. H., Wheelock, M. J., and Damjanov, I. Expression of the cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors. Am. J. Pathol., 135: 101-110, 1989.